162 related items for PubMed ID: 38803234
1. STAT3 inhibition ameliorates renal interstitial inflammation in MRL/lpr mice with diffuse proliferative lupus nephritis.
Zhu J, Chen Y, Chen Y, Lv Y, Chen T.
Ren Fail; 2024 Dec; 46(1):2358187. PubMed ID: 38803234
[Abstract] [Full Text] [Related]
2. S3I-201 ameliorates tubulointerstitial lesion of the kidneys in MRL/lpr mice.
Du Y, Zhang W, Liu S, Feng X, Gao F, Liu Q.
Biochem Biophys Res Commun; 2018 Sep 03; 503(1):177-180. PubMed ID: 29885836
[Abstract] [Full Text] [Related]
3. Anti-Ccl2 Spiegelmer permits 75% dose reduction of cyclophosphamide to control diffuse proliferative lupus nephritis and pneumonitis in MRL-Fas(lpr) mice.
Kulkarni O, Eulberg D, Selve N, Zöllner S, Allam R, Pawar RD, Pfeiffer S, Segerer S, Klussmann S, Anders HJ.
J Pharmacol Exp Ther; 2009 Feb 03; 328(2):371-7. PubMed ID: 18997060
[Abstract] [Full Text] [Related]
4. Interleukin-22 From Type 3 Innate Lymphoid Cells Aggravates Lupus Nephritis by Promoting Macrophage Infiltration in Lupus-Prone Mice.
Hu L, Hu J, Chen L, Zhang Y, Wang Q, Yang X.
Front Immunol; 2021 Feb 03; 12():584414. PubMed ID: 33717066
[Abstract] [Full Text] [Related]
5. Therapeutic effects of artesunate on lupus-prone MRL/lpr mice are dependent on T follicular helper cell differentiation and activation of JAK2-STAT3 signaling pathway.
Dang WZ, Li H, Jiang B, Nandakumar KS, Liu KF, Liu LX, Yu XC, Tan HJ, Zhou C.
Phytomedicine; 2019 Sep 03; 62():152965. PubMed ID: 31129432
[Abstract] [Full Text] [Related]
6.
; . PubMed ID:
[No Abstract] [Full Text] [Related]
7. Piperlongumine alleviates lupus nephritis in MRL-Fas(lpr) mice by regulating the frequency of Th17 and regulatory T cells.
Yao L, Chen HP, Ma Q.
Immunol Lett; 2014 Sep 03; 161(1):76-80. PubMed ID: 24837470
[Abstract] [Full Text] [Related]
8.
; . PubMed ID:
[No Abstract] [Full Text] [Related]
9. Anti-monocyte chemoattractant protein-1 gene therapy attenuates nephritis in MRL/lpr mice.
Shimizu S, Nakashima H, Masutani K, Inoue Y, Miyake K, Akahoshi M, Tanaka Y, Egashira K, Hirakata H, Otsuka T, Harada M.
Rheumatology (Oxford); 2004 Sep 03; 43(9):1121-8. PubMed ID: 15213333
[Abstract] [Full Text] [Related]
10. P-selectin blockade ameliorates lupus nephritis in MRL/lpr mice through improving renal hypoxia and evaluation using BOLD-MRI.
Zhang L, Chen S, Liu Y, Xu X, Zhang Q, Shao S, Wang W, Li X.
J Transl Med; 2020 Mar 05; 18(1):116. PubMed ID: 32138730
[Abstract] [Full Text] [Related]
11. Methylprednisolone attenuates lipopolysaccharide-induced Fractalkine expression in kidney of Lupus-prone MRL/lpr mice through the NF-kappaB pathway.
You Y, Qin Y, Lin X, Yang F, Li J, Sooranna SR, Pinhu L.
BMC Nephrol; 2015 Aug 27; 16():148. PubMed ID: 26310926
[Abstract] [Full Text] [Related]
12. Procyanidin B2 prevents lupus nephritis development in mice by inhibiting NLRP3 inflammasome activation.
He J, Sun M, Tian S.
Innate Immun; 2018 Jul 27; 24(5):307-315. PubMed ID: 29874961
[Abstract] [Full Text] [Related]
13. BTK inhibition ameliorates kidney disease in spontaneous lupus nephritis.
Chalmers SA, Glynn E, Garcia SJ, Panzenbeck M, Pelletier J, Dimock J, Seccareccia E, Bosanac T, Khalil S, Harcken C, Webb D, Nabozny G, Fine JS, Souza D, Klein E, Herlitz L, Ramanujam M, Putterman C.
Clin Immunol; 2018 Dec 27; 197():205-218. PubMed ID: 30339790
[Abstract] [Full Text] [Related]
14. Parasites alter the pathological phenotype of lupus nephritis.
Miyake K, Adachi K, Watanabe M, Sasatomi Y, Ogahara S, Abe Y, Ito K, Dan Justin YK, Saito T, Nakashima H, Hamano S.
Autoimmunity; 2014 Dec 27; 47(8):538-47. PubMed ID: 24957876
[Abstract] [Full Text] [Related]
15. Novel Effects of Combination Therapy Through Inhibition of Caspase-1/Gasdermin D Induced-Pyroptosis in Lupus Nephritis.
Cao H, Liang J, Liu J, He Y, Ke Y, Sun Y, Jiang S, Lin J.
Front Immunol; 2021 Dec 27; 12():720877. PubMed ID: 34867948
[Abstract] [Full Text] [Related]
16. Icariin alleviates murine lupus nephritis via inhibiting NF-κB activation pathway and NLRP3 inflammasome.
Su B, Ye H, You X, Ni H, Chen X, Li L.
Life Sci; 2018 Sep 01; 208():26-32. PubMed ID: 30146016
[Abstract] [Full Text] [Related]
17. Signal transducer and activator of transcription (STAT) 3 inhibition delays the onset of lupus nephritis in MRL/lpr mice.
Edwards LJ, Mizui M, Kyttaris V.
Clin Immunol; 2015 Jun 01; 158(2):221-30. PubMed ID: 25869298
[Abstract] [Full Text] [Related]
18. 1,25-dihydroxyvitamin D3 ameliorates lupus nephritis through inhibiting the NF-κB and MAPK signalling pathways in MRL/lpr mice.
Li X, Liu J, Zhao Y, Xu N, Lv E, Ci C, Li X.
BMC Nephrol; 2022 Jul 08; 23(1):243. PubMed ID: 35804318
[Abstract] [Full Text] [Related]
19. Upregulation of FoxO3a expression through PI3K/Akt pathway attenuates the progression of lupus nephritis in MRL/lpr mice.
Zhao C, Gu Y, Chen L, Su X.
Int Immunopharmacol; 2020 Dec 08; 89(Pt A):107027. PubMed ID: 33039957
[Abstract] [Full Text] [Related]
20. Anti-prolactin treatment alleviates lupus conditions by regulating the JAK2-STAT3 pathway.
Jiang Y, Chen H, Lin J, Pan J, Shen Y, Li Q.
Clin Exp Pharmacol Physiol; 2023 Dec 08; 50(12):936-943. PubMed ID: 37727880
[Abstract] [Full Text] [Related]
Page: [Next] [New Search]
